$VATE

IES Holdings (IESC) agreed to acquire DBM Global from INNOVATE (VATE) for about $650 million, including minority interests, paid with cash and IES common stock. IES plans to fund the cash portion via cash on hand and borrowings under an expanded Wells Fargo credit facility. DBM Global revenue was about $1.3 billion for the 12 months ended Mar. 31, 2026. Closing is expected in the quarter ending Dec. 31, 2026.

INNOVATE Corp. (VATE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-1.1 2 a20260810ex11-transactio.htm EX-1.1 a20260810ex11-transactio TRANSACTION AGREEMENT by and between IES HOLDINGS, INC., a Delaware corporation IES MERGER SUB, INC., a Delaware corporation DBM GLOBAL INTERMEDIATE HOLDCO INC., a Delaware corporation and INNOVATE CORP. a Dela

INNOVATE Corp. (VATE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-q22026pressrele.htm EX-99.1 Document FOR IMMEDIATE RELEASE INNOVATE Corp. Announces Second Quarter 2026 Results - Infrastructure: DBM Global delivered record results in the second quarter with year-over-year revenue growth of ~ 78% - Life Sciences: MediBeacon

INNOVATE Corp. (VATE) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 3 a20260803ex102-2027convert.htm EX-10.2 Document Exhibit 10.2 SUPPLEMENTAL INDENTURE THIS SUPPLEMENTAL INDENTURE (this “ Supplemental Indenture ”), dated as of July 31, 2026, by and among INNOVATE Corp. (f/k/a HC2 Holdings, Inc.), a Delaware corporation (the “ Company ”)

INNOVATE Corp. (VATE) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. hchc-20260611 false 0001006837 TRUE 0001006837 2026-06-11 2026-06-11 0001006837 hchc:CommonStockParValue0001PerShareMember 2026-06-11 2026-06-11 0001006837 hchc:PreferredStockPurchaseRightsMember 2026-06-11 2026-06-11 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D

INNOVATE Corp (VATE) will hold its 2026 annual shareholder meeting virtually on June 11, 2026, where stockholders will vote on electing four directors, an advisory vote on executive compensation, an increase in shares for the Omnibus Equity Award Plan, and ratifying BDO USA, P.C. as auditor. The board recommends voting "FOR" all proposals. The company also reported 2025 business highlights, including significant revenue growth for DBM Global and key product approvals for MediBeacon.

This article compares two small-cap conglomerate companies, INNOVATE (NYSE:VATE) and Reitar Logtech (NASDAQ:RITR), which operate in diverse sectors. It examines their business models, risk profiles, and financial metrics to help investors determine which might be a better investment. INNOVATE focuses on infrastructure, life sciences, and spectrum, while Reitar Logtech specializes in construction management, engineering design, and asset management services.

INNOVATE Corp (VATE) announced strong revenue growth for Q4 2025 and the full year, driven primarily by its Infrastructure segment. The company also secured FDA approval for its Life Sciences product and saw regulatory tailwinds in its Spectrum segment, despite some quarterly softness. However, TipRanks' AI Analyst Spark rates VATE as Neutral due to weak financial quality despite revenue growth.

INNOVATE Corp (VATE) announced that its subsidiary MediBeacon's transdermal glomerular filtration rate (tGFR) technology article was recognized as a 2025 Editors’ Choice by the Journal of the American Society of Nephrology. The TGFR System is now being clinically deployed in centers of excellence aimed at improving kidney function measurement for various medical applications. This recognition and deployment could establish MediBeacon’s technology as a new standard of care, bolstering INNOVATE's position in the life sciences sector.

This page provides the latest stock news and market updates for Innovate Corp (NYSE: VATE), covering recent financial results, strategic initiatives, and operational milestones across its infrastructure, life sciences, and spectrum technology sectors. Key updates include FDA approval for MediBeacon's TGFR System, Innovate's Q3 2025 earnings, DBM Global dividend announcements, and successful debt refinancing efforts. The company's subsidiaries like R2 Technologies also show significant growth in aesthetic innovation.